Low-Density Lipoprotein Cholesterol Treatment Rates in High Risk Patients: More Disappointment Despite Ever More Refined Evidence-Based Guidelines.

Low-Density Lipoprotein Cholesterol Treatment Rates in High Risk Patients: More Disappointment Despite Ever More Refined Evidence-Based Guidelines.

Bibliographic Details
Main Author:	Peter P. Toth, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2021-06-01
Series:	American Journal of Preventive Cardiology
Subjects:	Atherosclerotic cardiovascular disease Ezetimibe Lipid-lowering therapy Low-density lipoprotein cholesterol Myocardial infarction Statin
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666667721000416

Similar Items

LDL Cholesterol Variability Impacts the Prognosis of Patients with Chronic Ischemic Heart Disease: A Real-World Italian Experience
by: Pompilio Faggiano, et al.
Published: (2023-09-01)

Time‐Dependent Cardiovascular Treatment Benefit Model for Lipid‐Lowering Therapies
by: Irfan Khan, et al.
Published: (2020-08-01)

Target Low-Density Lipoprotein-Cholesterol and Secondary Prevention for Patients with Acute Myocardial Infarction: A Korean Nationwide Cohort Study
by: Ju Hyeon Kim, et al.
Published: (2022-05-01)

Response by sex to statin plus ezetimibe or statin monotherapy: A pooled analysis of 22,231 hyperlipidemic patients
by: Lin Jianxin, et al.
Published: (2011-08-01)

Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines
by: Levintow SN, et al.
Published: (2020-08-01)

Age-Dependent Efficacy of Ezetimibe for Low-Density Lipoprotein Cholesterol Reduction in Japanese Patients with or without Type 2 Diabetes Mellitus
by: Satoshi Yamaguchi, et al.
Published: (2020-06-01)

Forty‐eight weeks of statin therapy for type 2 diabetes mellitus patients with lower extremity atherosclerotic disease: Comparison of the effects of pitavastatin and atorvastatin on lower femoral total plaque areas
by: Xieda Zhou, et al.
Published: (2021-07-01)

Low-Density Lipoprotein Cholesterol-Lowering Drugs: A Narrative Review
by: Nicola Ferri, et al.
Published: (2024-02-01)

Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low‐Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients
by: Ted Okerson, et al.
Published: (2017-03-01)

Low-density lipoprotein-cholesterol lowering effect of a nutraceutical regimen with or without ezetimibe in hypercholesterolaemic patients with statin intolerance
by: Natalie C. Ward, et al.
Published: (2022-11-01)

Lipid Testing Trends Before and After Hospitalization for Myocardial Infarction Among Adults in the United States, 2008–2019
by: Levintow SN, et al.
Published: (2022-06-01)

Impact of combination therapy with statin and ezetimibe on secondary prevention for post-acute myocardial infarction patients in the statin era
by: Soichiro Ebisawa, et al.
Published: (2015-09-01)

From intensive statins to intensive lipid lowering: Amplitude of low-density lipoprotein-cholesterol lowering is the core for atherosclerosis cardiovascular disease prevention
by: Daoquan Peng
Published: (2018-01-01)

Updated Understanding of the Crosstalk Between Glucose/Insulin and Cholesterol Metabolism
by: Xuan Xiao, et al.
Published: (2022-04-01)

Discordance Between Very Low‐Density Lipoprotein Cholesterol and Low‐Density Lipoprotein Cholesterol Increases Cardiovascular Disease Risk in a Geographically Defined Cohort
by: Kristina E. Seehusen, et al.
Published: (2024-04-01)

Application of the very high risk criterion and evaluation of cholesterol guideline adherence in acute myocardial infarction patients at an urban academic medical center
by: Adam J. Brownstein, et al.
Published: (2022-01-01)

Short-Course High-Intensity Statin Treatment during Admission for Myocardial Infarction and LDL-Cholesterol Reduction—Impact on Tailored Lipid-Lowering Therapy at Discharge
by: Víctor Marcos-Garcés, et al.
Published: (2023-12-01)

Low density lipoprotein cholesterol reduction for the prevention of cardiovascular disease: Newer concepts
by: Shamanna S Iyengar
Published: (2016-01-01)

Efficacy of Ezetimibe/Simvastatin (10/10 mg) Versus High Dose Statin in Dyslipidemia Patients: A Meta-Analysis of Randomized Controlled Trials
by: Gaoming YANG, et al.
Published: (2019-07-01)

Perfluoroalkyl Substance Serum Concentrations and Cholesterol Absorption-Inhibiting Medication Ezetimibe
by: Ge Ma, et al.
Published: (2022-12-01)

Non-High-Density lipoprotein cholesterol or Apolipoprotein B in the prediction of myocardial infarction
by: Amit Kumar Pradhan, et al.
Published: (2017-04-01)

Higher Cholesterol Absorption Marker at Baseline Predicts Fewer Cardiovascular Events in Elderly Patients Receiving Hypercholesterolemia Treatment: The KEEP Study
by: Masanari Kuwabara, et al.
Published: (2024-02-01)

REDUCTION DEGREE OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL LEVELS ACCORDING TO DIFFERENT DOSES OF STATINS; ITS EFFECT ON THE RISK OF ISCHEMIC HEART DISEASE ACUTE EPISODES DEPENDING ON TREATMENT DURATION; AND RISK OF ISCHEMIC AND THROMBOEMBOLIC STROKE. COMMENT ON THE PAPER OF LAW M.R., WALD N.J., RUDNICKA A.R. QUANTIFYING EFFECT OF STATINS ON LOW DENSITY LIPOPROTEIN CHOLESTEROL, ISCHAEMIC HEART DISEASE, AND STROKE: SYSTEMATIC REVIEW AND META-ANALYSIS. BMJ 2003; 326:1423-1427
by: N. V. Perova
Published: (2016-01-01)

Predictive and Prognostic Value of High-density Lipoprotein Cholesterol in Young Male Patients with Acute Myocardial Infarction
by: Zhao Li, et al.
Published: (2017-01-01)

Predictive Value of Remnant Lipoprotein-cholesterol and Atherogenic Index of Plasma for First-time Acute Myocardial Infarction in Young Adults
by: DENG Yifan, ZHU Mixue, LIU Juan, NIE Ri, HE Shenghu, ZHANG Jing
Published: (2023-02-01)

Executive summary of the Hellenic Atherosclerosis Society guidelines for the diagnosis and treatment of dyslipidemias - 2023
by: N Katsiki, et al.
Published: (2024-03-01)

The ratio of total cholesterol to high density lipoprotein cholesterol and myocardial infarction in Women’s health in the Lund area (WHILA): a 17-year follow-up cohort study
by: Susanna Calling, et al.
Published: (2019-10-01)

Age‐Related Associations of Low‐Density Lipoprotein Cholesterol and Atherosclerotic Cardiovascular Disease: A Nationwide Population‐Based Cohort Study
by: Han Na Jung, et al.
Published: (2022-05-01)

Effects of lipid-lowering treatment intensity and adherence on cardiovascular outcomes in patients with a recent myocardial infarction: a Swedish register-based study
by: Maria K. Svensson, et al.
Published: (2022-05-01)

Factors Associated With Enhanced Low‐Density Lipoprotein Cholesterol Lowering With Bempedoic Acid
by: Christie M. Ballantyne, et al.
Published: (2022-08-01)

Real-World Attainment of Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Cardiovascular Disease Treated with High-Intensity Statins: The TERESA Study
by: Vivencio Barrios, et al.
Published: (2023-04-01)

Analysis of Serum Lipid Level and Drug Use in Patients with Acute Myocardial Infarction
by: LIU Chuanfen, LI Zheng, WU Manyan, CUI Yuxia, SONG Jing, ZHANG Chunying, CHEN Hong
Published: (2023-04-01)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
by: Niki Katsiki, et al.
Published: (2023-04-01)

Efficacy and safety of bempedoic acid alone or combining with other lipid-lowering therapies in hypercholesterolemic patients: a meta-analysis of randomized controlled trials
by: Xiang Zhao, et al.
Published: (2020-12-01)

There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness
by: Michael E. Makover, et al.
Published: (2022-12-01)

Effect of combined lipid-lowering therapy on atherosclerotic plaque vulnerability in patients with acute coronary syndrome (Combi-LLT ACS): randomized trial protocol
by: A. N. Kovalskaya, et al.
Published: (2022-12-01)

Co-Amorphous Formation of Simvastatin-Ezetimibe: Enhanced Physical Stability, Bioavailability and Cholesterol-Lowering Effects in LDLr−/−Mice
by: Shamuha Bahetibieke, et al.
Published: (2022-06-01)

Beyond Statins: Novel Lipid-Lowering Agents for Reducing Risk of Atherosclerotic Cardiovascular Disease
by: Teimur Kayani, et al.
Published: (2024-03-01)

Association of High-Density Lipoprotein Cholesterol Phenotypes with the Risk of Cardiovascular Diseases and Mortality: A Cohort Study in Korea
by: Ga Eun Nam, et al.
Published: (2022-04-01)

Antiatherosclerotic Effects of CSL112 Mediated by Enhanced Cholesterol Efflux Capacity
by: Bronwyn A. Kingwell, et al.
Published: (2022-04-01)